Publication | Closed Access

Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial–mesenchymal transition

Gastrointestinal OncologyGastrointestinal PharmacologyMedicineEpithelial–mesenchymal TransitionPharmacologyCancer Cell BiologyProton Pump InhibitorAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchTumor BiologyAkt/gsk-β/β-catenin Signaling